BioSpace News Archive

aTyr Pharma, Inc. today announced that the company will present clinical and preclinical data for efzofitimod (ATYR1923), its lead therapeutic candidate, in three posters at the American Thoracic Society (ATS) 2022 International Conference, which is being held May 13 – 18, 2022, in San Francisco, CA.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® vascular dose in reducing severe vascular events in patients with PAD after lower-extremity revascularization, a procedure that restores blood flow to the legs.

McKesson Corporation announced that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022.

Teva to Present New Analyses of AJOVY ® (fremanezumab-vfrm) Injection and AUSTEDO ® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting.

Fortress Biotech, Inc. today announced a two-day summit hosted by the B. Riley Securities’ Healthcare Equity Research team, that will feature multiple programs from Fortress’ diversified pipeline.

Spexis AG a clinical-stage biopharmaceutical company, focused on rare diseases and oncology with an initial focus on chronic respiratory diseases published the invitation to its Annual General Meeting on April 26, 2022.

Takeda announced that its Board of Directors will propose two new candidates for independent external directors at the 146th Ordinary Meeting of Shareholders on June 29, 2022.

CONMED Corporation announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022.

Celsion Corporation today announced the company reported a cash position of $56.9 million as of December 31, 2021 during its earnings announcement on March 31, 2022.

Qualigen Therapeutics, Inc. today announces its financial results for the fiscal year ended December 31, 2021.